{
    "clinical_study": {
        "@rank": "126102", 
        "arm_group": {
            "arm_group_label": "Corneal Cross-linking", 
            "arm_group_type": "Experimental", 
            "description": "ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) using UVA light and the photo- mediator riboflavin"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced\n      cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and\n      biochemical stability of the cornea by inducing additional cross-links within or between\n      collagen fibers using UVA light and the photo- mediator riboflavin."
        }, 
        "brief_title": "A Study of Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Keratoconus", 
        "condition_browse": {
            "mesh_term": "Keratoconus"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. 8 years of age or older\n\n          2. Having at least one of the following conditions:\n\n               -  Keratoconus\n\n               -  Post-LASIK ectasia\n\n               -  Pellucid marginal degeneration\n\n               -  Forme fruste pellucid marginal degeneration\n\n               -  FFKC\n\n               -  History of Radial Keratotomy with fluctuating vision.\n\n               -  Terrien's Marginal Degeneration\n\n          3. Signed written informed consent and/or assent\n\n          4. Likely to complete all study visits\n\n          5. Minimum corneal thickness of at least 250 microns measured by ultrasound or Pentacam\n             for all indications other than Terrien's. For Terrien's, the minimal corneal\n             thickness should be consistent with the surgeon's best surgical judgment.\n\n        Exclusion Criteria:\n\n          1. Severe corneal scarring that markedly affects vision\n\n          2. Contraindications to any study medications or their components\n\n          3. Pregnancy or breast feeding\n\n          4. Active Herpes Corneal Disease"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "1500", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01956474", 
            "org_study_id": "CXL-04"
        }, 
        "intervention": {
            "arm_group_label": "Corneal Cross-linking", 
            "intervention_name": "Theralight crosslinking and Riboflavin", 
            "intervention_type": "Device"
        }, 
        "intervention_browse": {
            "mesh_term": "Riboflavin"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "keratoconus", 
            "cross-linking", 
            "Post-LASIK ectasia", 
            "Pellucid marginal degeneration", 
            "Forme fruste pellucid marginal degeneration", 
            "FFKC", 
            "Radial Keratotomy", 
            "Terrien's Marginal Degeneration"
        ], 
        "lastchanged_date": "May 7, 2014", 
        "location": [
            {
                "contact": {
                    "email": "mattyceec@bellsouth.net", 
                    "last_name": "Matty Infante"
                }, 
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33176"
                    }, 
                    "name": "Center for Excellence in Eye Care"
                }, 
                "investigator": {
                    "last_name": "William Trattler, MD", 
                    "role": "Sub-Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "ddichiara@woolfsoneye.com", 
                    "last_name": "Debbie Dichiara"
                }, 
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30328"
                    }, 
                    "name": "Stulting Research Center at Woolfson Eye Institute"
                }, 
                "investigator": {
                    "last_name": "Robert Stulting, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sismerritt@gmail.com", 
                    "last_name": "Stephanie Merritt"
                }, 
                "facility": {
                    "address": {
                        "city": "Rockville", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "20852"
                    }, 
                    "name": "TLC Laser Eye Center"
                }, 
                "investigator": {
                    "last_name": "Levy Marc, OD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "MRivera@lasikofboston.com", 
                    "last_name": "Migdali Rivera"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02451"
                    }, 
                    "name": "Talamo Hatch Laser Eye Consultants, LLC"
                }, 
                "investigator": {
                    "last_name": "Johnathan Talamo, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "kkeaton@clevelandeyeclinic.com", 
                    "last_name": "Karen Keaton"
                }, 
                "facility": {
                    "address": {
                        "city": "Brecksville", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "44141"
                    }, 
                    "name": "Cleveland Eye Clinic"
                }, 
                "investigator": {
                    "last_name": "Shamik Bafna, MD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "sismerritt@gmail.com", 
                    "last_name": "Stephanie Merritt"
                }, 
                "facility": {
                    "address": {
                        "city": "Fairfax", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "22031"
                    }, 
                    "name": "TLC Laser Eye Center"
                }, 
                "investigator": {
                    "last_name": "Marc Levy, OD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Collagen Crosslinking With Ultraviolet-A in Asymmetric Corneas", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in Best Spectacle Corrected Visual Acuity (BSCVA)", 
            "safety_issue": "Yes", 
            "time_frame": "6-9 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01956474"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in Uncorrected Visual Acuity (UCVA)", 
                "safety_issue": "Yes", 
                "time_frame": "6-9 months"
            }, 
            {
                "measure": "Change in Corneal topography", 
                "safety_issue": "Yes", 
                "time_frame": "6-9 months"
            }, 
            {
                "measure": "Change in Manifest Refraction", 
                "safety_issue": "No", 
                "time_frame": "6-9 months"
            }, 
            {
                "measure": "Change in Keratometry on topography and Pentacam", 
                "safety_issue": "No", 
                "time_frame": "6-9 months"
            }, 
            {
                "measure": "Change in Wavefront Refraction and aberrations", 
                "safety_issue": "No", 
                "time_frame": "6-9 months"
            }
        ], 
        "source": "Cxlusa", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cxlusa", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}